Application no. and date | 13157571.4 (espacenet) (Federated) (European Patent Register), 20100416 | Patent/reg. no. and date | DK/EP 2601949, 20141029 | Publication date | 20130612 | Priority no. and date | JP 2009100210, 20090416 | EP pub. no. and date |
EP 2601949 20130612 | Effective date | | Applicant/owner | Taisho Pharmaceutical Co., Ltd., 24-1, Takada 3-chome Toshima-ku Tokyo 170-8633, JP | Applicant ref. no. | 158525 | Inventor | Takahashi, Teisuke, c/o TAISHO PHARMACEUTICAL CO., LTD. 24-1, Takada 3-chome Toshima-ku
Tokyo, 170-8633, JP, Uchida, Saeko, c/o TAISHO PHARMACEUTICAL CO., LTD. 24-1, Takada 3-chome Toshima-ku
Tokyo, 170-8633, JP | Representative | AWA Denmark A/S, Strandgade 56, 1401 København K, DK | Opponent | | IPC Class | A61K 31/155 (2006.01) , A61K 31/382 (2006.01) , A61K 31/4439 (2006.01) , A61K 31/64 (2006.01) , A61K 45/00 (2006.01) , A61P 13/12 (2006.01) , A61P 25/00 (2006.01) , A61P 27/02 (2006.01) , A61P 3/10 (2006.01) , A61P 43/00 (2006.01) , A61P 5/50 (2006.01) , A61P 9/10 (2006.01) , A61P 9/14 (2006.01) , C07D 335/02 (2006.01) | Title | Farmaceutisk sammensætning med (1S)-1,5-anhydro-1-[5-(4-ethoxybenzyl)-2-methoxy-4-methylphenyl]-1-thio-D-glucitol og et insulin-sekretionsfremkaldende stof | Int. application no. | | Int. publication no. | | Related patent (certificate) | | Status | Bortfaldet | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|